Gemcabene for the Treatment of Pediatric NAFLD: A Phase 2a Study
Phase of Trial: Phase II
Latest Information Update: 13 Apr 2018
At a glance
- Drugs Gemcabene (Primary)
- Indications Non-alcoholic fatty liver disease
- Focus Pharmacodynamics; Proof of concept
- 09 Apr 2018 Status changed from not yet recruiting to recruiting.
- 06 Mar 2018 Planned initiation date changed from 1 Feb 2018 to 1 Mar 2018.
- 11 Feb 2018 Status changed from recruiting to not yet recruiting.